Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 : a randomized clinical trial
Foilsithe in: | Nature Cancer 4(2023)1, S. 96-107 |
---|---|
Príomhchruthaitheoirí: | , , , |
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
2023
|
Ábhair: | |
Rochtain ar líne: | https://doi.org/10.1038/s43018-022-00503-w |
Le fáil in: | In:
Nature Cancer |
Cur síos ar an mír: | Exemplar/Standort: Open Access |
---|---|
DOI: | 10.1038/s43018-022-00503-w |
Gairmuimhir: | Open Access |